Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-night crossover study of AD047 and AD282 in obstructive sleep apnoea
ACTRN12618001181291Phase 2Completed
- Sponsor
- Apnimed, Inc.
- Start
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in obstructive sleep apnea hypopnea syndrome (OSAHS) comparing AD047, AD282 and Placebo (3 arms). Primary endpoint: Apnoea/hypopnoea index. Started Aug 2018; status: completed.
02
Drugs
AD047AD282
03
Conditions
obstructive sleep apnea hypopnea syndrome (OSAHS)
Beyond the preview
Go deeper on ACTRN12618001181291.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12618001181291.